<i>CREBBP</i> histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphomaEmil Kumar, Jessica Okosun, James A. Heward et al.|British Journal of Haematology|2024Cited by 1
PF513 MUTATIONS AFFECTING THE CREBBP HAT DOMAIN PREDICT RESPONSE TO MTOR INHIBITORS EVEROLIMUS AND TEMSIROLIMUS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMAEmil Kumar, Jude Fitzgibbon, Koorosh Korfi et al.|HemaSphere|2019Cited by 0